A Phase IIb, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the safety, tolerability and efficacy of Study Drug in adults with chronic hepatitis C virus infection.
Feasibility Defines a Unique Enrollment Strategy
PRA recently performed a feasibility study to identify investigators who see patients with a rare neuromuscular autoimmune disease and who have the…
Overcoming Recruitment Challenges to Meet Vaccine Study Enrollment
Through an enhanced enrollment plan, PRA helped a client meet challenging enrollment goals in a vaccine study. Our innovative strategies contributed…
Complex Feasibility Assessment in Low- & Middle-Income Countries
Complex Feasibility Assessment in Low- & Middle-Income Countries.